Concluded Case

UPDATE ON DAPAGLIFLOZIN IN NON DIABETIC CKD, PROTEINURIA & WEIGHT LOSS

Dear my friends and fellow Colleagues, Here is an update on DAPAGLIFLOZIN. 6-week treatment with dapagliflozin did not affect proteinuria in patients with chronic kidney disease without diabetes. But did show a significant reduction in bodyweight. (Lancet Diabetes Endocrinol 2020; 8: 58293) Regards and thanks, Dr Sepuri Krishna Mohan.

6 Likes

LikeAnswersShare
Concluded answer

Thank you, Sir , for useful update

All Answers

Sir, is there any side effect like UTI as seen with Canagliflozin?

Absolutely yes. That's a Class Effect of all SGLT2 Inhibitors
0

View 1 other reply

Thank you, Sir , for useful update

Valuable opinion
0

View 1 other reply

Useful updaes.very helpful.

Thank you doctor
0